Where does National Hospital Organization rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), National Hospital Organization ranks #26,941 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does National Hospital Organization hold?

National Hospital Organization holds 10 US utility patents granted between 2017 and 2022, spanning 11 technology areas.

What is National Hospital Organization's Innovation Score?

National Hospital Organization has an Innovation Score of 26.2 out of 100 (19th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does National Hospital Organization focus on?

National Hospital Organization's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is National Hospital Organization's patent grant rate increasing or decreasing?

National Hospital Organization's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for National Hospital Organization's patents?

National Hospital Organization's patents average 8.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the National Hospital Organization patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Hospital Organization

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, National ranks #26,941 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#26,941
of 49,997 US assignees by volume: 19th percentile
by Innovation Score (26.2/100): 8.4
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26941 · Foreign Corporation #26,941 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,941/49,997
PHOTO-FINISH Nantong Institute…
CPC-FOCUS A61P · 11 areas
INNOV-THIN 26.2/100
CLAIMS-PAR 8.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nantong Institute OF Nanjing University OF Posts AND Telecommunications Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 26.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (32%) Velocity 1.1 pts (4%) Breadth 11.7 pts (45%) Claim depth 5.0 pts (19%)

Qualcomm Incorporated · highest

85
National Hospital… · this assignee

26
3D Lighting… · lowest

7

What this shows National's Innovation Score is 26.2/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 8.4 claims/patent is at or below the 8.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Hospital Organization is a focused PatentsView assignee: 11 CPC subclasses with 50% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2018. By volume, National sits between Nantong Institute OF Nanjing University OF Posts AND Telecommunications Co., Ltd. and NEW Kailung Gear Co., Ltd.

National's three-year grant acceleration

National Hospital Organization shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nantong Institute…

10
Napo Pharmaceutic…

10
National Center F…

10
National Disaster…

10
Netlogic Microsys…

10
Neuvivo

10
Nevada Research &…

10
NEW Kailung Gear

10
National Hospital… ◀

10

What this shows National holds 10 patents at rank #26,925, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #26,925 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 19th percentile higher than 19% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

National Hospital Organization patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	20.0%
2018	1	10.0%
2019	5	50.0%
2020	1	10.0%
2022	1	10.0%

Which technologies does National Hospital Organization patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C07D - Heterocyclic Compounds 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 2

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

National Hospital Organization's patent record in context - here's where to go next.

National Hospital Organization's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 50% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #26,941 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare National Hospital Organization against Nantong Institute OF Nanjing University OF Posts AND Telecommunications Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.